Search results
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 1 day agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...
Pfizer: Q1 Earnings Snapshot
Midland Reporter-Telegram· 1 day agoNEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Wednesday reported first-quarter...
Pfizer beats earnings estimates months after stock dipped to record lows
Crain's New York Business· 16 hours agoWhen excluding Pfizer’s Covid products, revenues increased 11%, indicating the success of its $43 billion acquisition of oncology firm Seagen and sales of blockbuster drugs ...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 1 day agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology via Yahoo Finance· 2 days agoPfizer and Genmab’s Tivdak (tisotumab vedotin-tftv) has won full approval from the US Food and Drug...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 1 day agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
Analyst Report: Pfizer Inc.
Morningstar Research via Yahoo Finance· 21 hours agoPfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types ...
Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 6 days agoBeyond analysts' top -and-bottom-line estimates for Pfizer (PFE), evaluate projections for some of...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 3 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
FierceBiotech· 20 hours agoPfizer’s 2024 revival tour is off and running, but the Big Pharma remains mum on one critical...